The Cigna Group Q3 EPS Forecast Decreased by Leerink Partnrs

The Cigna Group (NYSE:CI) – Equities research analysts at Leerink Partnrs reduced their Q3 2025 earnings per share (EPS) estimates for The Cigna Group in a report issued on Sunday, May 4th. Leerink Partnrs analyst W. Mayo now forecasts that the health services provider will post earnings of $7.97 per share for the quarter, down from their prior forecast of $8.22. The consensus estimate for The Cigna Group’s current full-year earnings is $29.77 per share. Leerink Partnrs also issued estimates for The Cigna Group’s Q4 2025 earnings at $7.89 EPS, Q2 2026 earnings at $7.90 EPS, Q3 2026 earnings at $8.74 EPS and Q4 2026 earnings at $8.58 EPS.

The Cigna Group (NYSE:CI) last announced its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same quarter last year, the business earned $6.47 earnings per share. The company’s revenue for the quarter was up 14.4% compared to the same quarter last year.

Several other brokerages have also recently issued reports on CI. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a report on Friday, January 31st. Oppenheimer cut their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research report on Friday, January 31st. Cantor Fitzgerald boosted their target price on shares of The Cigna Group from $350.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, March 20th. Stephens cut their price target on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Finally, Truist Financial upped their price objective on The Cigna Group from $375.00 to $385.00 and gave the company a “buy” rating in a report on Friday, April 11th. Two analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and an average target price of $378.22.

The Cigna Group Price Performance

CI stock opened at $334.55 on Tuesday. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The firm has a market capitalization of $89.37 billion, a PE ratio of 27.33, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The business has a 50 day simple moving average of $324.90 and a 200-day simple moving average of $309.92.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group’s dividend payout ratio is presently 33.44%.

Insiders Place Their Bets

In other news, Director Elder Granger sold 2,376 shares of the business’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares of the company’s stock, valued at approximately $1,697,924.85. The trade was a 30.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani sold 26,527 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now directly owns 127,767 shares of the company’s stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock valued at $13,603,991 in the last ninety days. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On The Cigna Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. TCTC Holdings LLC purchased a new position in The Cigna Group during the 4th quarter worth $25,000. Collier Financial purchased a new position in shares of The Cigna Group during the fourth quarter worth about $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group in the 4th quarter valued at about $34,000. Putney Financial Group LLC purchased a new stake in The Cigna Group during the 4th quarter valued at approximately $36,000. Finally, Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group during the 4th quarter worth approximately $37,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.